Purpose of the development: Intended for the treatment of patients on cider increased fatigue with chronic diseases of the hepatobiliary system.

Recommended application field: The invention relates to the field of medicine, namely, clinical immunology and internal medicine.

The development stage readiness: Introduced in production

Description of the development:
()
Relevance of subject matter of the utility model is associated with a significant spread in the population of large industrial areas, including the Donbas, in which the environment polluted with chemical hazards, increased fatigue syndrome (SPU), which is often connected with chronic liver disease and zhelchevyvodnyh tract (chronic cholecystitis nekalkuleznogo, nealkogolny steatohepatitis). Therefore highly relevant is the development of rational methods of treating this komoridnogo pathological condition. The novelty lies in the fact that in addition to Erbisol cholera patients and Antral gepatoproektor livolin injected into stage I of the ATP (compensated) - 1 capsule 3 times a day for 15-20 days in a row, with stage II (subkompensovannoy) - 2 capsules 3 times a day for 15-20 days and III stage (decompensated) - 2 capsules four times a day for 20-30 days in a row.

Information about newness of the development:
there are Ukrainian patents -- 1 items

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua